Pharmaceutical Supply – Ophthalmic Antibiotic Medication

The contract involves the manufacture and supply of a sterile ophthalmic ointment containing Neomycin and Polymyxin B Sulfates and Hydrocortisone, specifically designated for medical use by the Department of Defense. This is a subcontract under the Defense Logistics Agency, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing, ensuring the product meets stringent sterility and quality standards required for military healthcare applications. The ointment is intended for treatment of bacterial eye infections and associated inflammation, with strict compliance to military specifications governing formulation, packaging, labeling, and storage conditions. Delivery is scheduled under the contract number SPE2D926F7339, with all production and supply activities aligned to support DoD medical readiness requirements. The agreement requires adherence to regulatory and operational guidelines for pharmaceuticals used in defense settings, including potential audits, quality assurance protocols, and timely fulfillment of demand forecasts. The contract was posted on July 14, 2026, and is managed through the DLA’s procurement system, underscoring its role in maintaining a reliable pharmaceutical supply chain for deployed personnel and military medical facilities.